Partnership in product development and manufacturing

Professional partnerships are central to our strategy in R & D and manufacturing. We know the international pharmaceutical community and we know our strengths and how to match them with the right partners.

Weifa’s R&D focus is directed at two key areas:

•    Healthy living: Bringing to market products that promote health, prevent illness and treat common health complaints, including OTC drugs, medical devices, nutraceuticals and cosmeceuticals
•    Medical therapy: Bringing to market products that meet patients’ medical needs and provide effective relief from or prevent illness, including prescription drugs, API synthesis development and innovative formulations

Geared for partnership

Our highly skilled R & D organisation is geared for partnership across the different stages of product development – from market research and new product conceptualisation through pharmaceutical chemistry , product formulation , manufacturing and control to clinical research and regulatory strategy. An extensive network of partners already contributes to our development projects, including international  Contract Research Organisations (CROs). Our modern production facilities in Kragerø, Norway also form an essential part of our offering. In combination, these assets make us well equipped to engage in a range of different partnership models, including co-development projects.

Co-development partnership

Weifa is continuously seeking partners to join us in co-development efforts. In particular we are looking for companies with proven technologies in solid oral formulations and/or substances (VAFD), medicinal products – both Rx and OTC – as well non-medicinal products like medical devices and nutraceuticals. Targeting market exclusivity and broad market impact, we are open for different types of cooperation models that equally benefit both parties.

A wide range of capabilities

The model below details the wide range of capabilities Weifa can offer its partners in R & D and manufacturing:

Model of what Weifa can offer their partners

Likewise, we have developed extensive skills and experience in regulatory work and other key disciplines required to bring new products to the market:

Graphic Weifa RD competencies

 

Are you our next partner?

Weifa has set out on an ambitious journey of growth and expansion, including an intensified effort in R & D and manufacturing. Provided the right match of ambitions and professional focus, we can offer a rewarding experience for those who want to join us.

For more information, please contact:

Astrid T. Bratvedt

Vice President R&D
astrid.bratvedt@weifa.no

Contact us

Astrid T. Bratvedt

Vice President R&D
astrid.bratvedt@weifa.no

Related articles

Research and development

Continuous and targeted research and development is central to Weifa’s strategy. Efforts are directed at two key areas – healthy living and therapeutic treatment. Our highly skilled R&D organisation is geared for partnership across all stages of the R & D value chain.

Production

At two modern plants in Kragerø, Norway, Weifa produces active pharmaceutical ingredients (APIs) and finished products in compliance with the most stringent industry standards. Weifa’s strong reputation for reliability and quality is founded here.

Quality

At Weifa, well-proven quality systems govern activities across the value chain – from the reception of raw material to the distribution of finished products. We systematically build quality into all steps of the process and into the mind-set of all employees.